2Suppliers
1Customers
2Debt Items
20Related Chains

Mosaic ImmunoEngineering, Inc. Suppliers

TickerNameConfidenceEvidence
INVESTOR INVESTOR 90% On November 18, 2024, we entered into an unsecured convertible promissory note ("Note Purchase Agreement") with an accredited investor ("Investor") for proceeds of up to $200,000 to be used for gener…
CWRU CWRU 85% On May 4, 2022 we exercised our rights under the License Option Agreement and entered into a license agreement with CWRU ("License Agreement"). Pursuant to the terms of the License Agreement, we agre…

Mosaic ImmunoEngineering, Inc. Customers

TickerNameConfidenceEvidence
ONCOTELIC ONCOTELIC 92% On July 1, 2024, we entered into a Master Services Agreement with Oncotelic whereby we perform advisory and related services in connection with studies and projects. During the years ended December 3…

Mosaic ImmunoEngineering, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CPMV-DEBT Debt stack $1.7M 90% Market cache reports total debt of $1.7M.
CPMV-DEBT-8818 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.

Mosaic ImmunoEngineering, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Mosaic ImmunoEngineering, Inc..

Mosaic ImmunoEngineering, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Mosaic ImmunoEngineering, Inc..

Mosaic ImmunoEngineering, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CHRS Coherus Oncology, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
AZN AstraZeneca PLC 100.00 1 ['receiving']
BNBX BNB Plus Corp. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
IMMP Immutep Limited 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BEAM Beam Therapeutics Inc. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
DEO Diageo plc 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 2